Delivery Order SPE2DB24D2100-SPE2DB25FBBCA
Award Date 11/27/24
Potential Completion Date 11/29/24
Potential Value $7.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $7,463.19 for the supply of GARDASIL 9 SYRINGE 0.5ML. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of July 3, 2025. The contract is a Firm Fixed Price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and there are no subcontractors mentioned. The...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order valued at $3,494.92 for the supply of GARDASIL 9 SYRINGE 0.5ML. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside. The contract has an Ultimate Completion Date of July 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $15,075.49 for the supply of GARDASIL 9 SYRINGE 0.5ML. The contract, which is a firm fixed price arrangement, was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of July 11, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $18,153.48 with a firm fixed price and an ultimate completion date of April 7, 2025. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of GARDASIL 9 SYRINGE 0.5ML. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,112.25 firm fixed-price delivery order is for GARDASIL 9 SYRINGE 0.5ML, with a completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,875.00 firm-fixed-price delivery order is for the provision of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $8,728.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of GARDASIL 9 syringes (0.5 mL). The contract has an ultimate completion date of November 25, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,166.42 firm fixed-price delivery order is for the supply of GARDASIL 9 syringes (0.5 mL). The contract has an ultimate completion date of January 30, 2025 and was awarded on January 29, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,553.85 fixed-price delivery order is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp. (a major pharmaceutical distributor) is a delivery order valued at $4,867.35 for the provision of GARDASIL 9 syringe 0.5ML, a vaccine product. The award was made by the Defense Logistics Agency (DLA), a defense agency, on November 21, 2024, with a completion date of November 22, 2024. The contract is a firm fixed-price delivery order and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen...